Article
Evaluation of an automated screening assay for von Willebrand disease type 2N.
Clinical and laboratory haematology - 1 Dec 2002
Taylor S L, Bromidge E, Savidge G F, Alhaq A
Abstract excerpt
Evaluating the factor VIII (FVIII) binding activity of von Willebrand factor (VWF) is an important step in the diagnostic work-up of families affected by apparent mild haemophilia A. In von Willebrand's disease (VWD) type 2N (Normandy), mutations at the N-terminal end of the mature VWF subunit gene prevent the binding of FVIII. Individuals heterozygous for type 2N VWD are generally asymptomatic. Homozygotes and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.